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Abstract. In this paper, we propose an approach of semantically en-
abled systems for clinical trials. The goals are not only to achieve the
interoperability by semantic integration of heterogeneous data in clini-
cal trials, but also to facilitate automatic reasoning and data processing
services for decision support systems in various settings of clinical trials.
We have implemented the proposed approach in a system called Se-
manticCT. SemanticCT is built on the top of LarKC (Large Knowledge
Collider), a platform for scalable semantic data processing. SemanticCT
has been integrated with large-scale trial data and patient data, and
provided various automatic services for clinical trials, which include au-
tomatic patient recruitment service (i.e., identifying eligible patients for
a trial) and trial finding service (i.e., finding suitable trials for a patient).
1 Introduction
Clinical trials provide tests which generate safety and efficacy data for health
interventions. Clinical trials usually involve large-scale and heterogeneous data.
The lack of integration and of semantic interoperability among the systems of
clinical trials and the systems of patient data, i.e. electronic health record (EHRs)
and clinical medical records (CMRs), is the main source of inefficiency of clinical
trial systems. Thus, many procedures in clinical trials, such as patient recruit-
ment (i.e., identifying eligible patients for a trial) and trial finding (i.e., finding
suitable trials for a patient), have been considered to be laborious.
Enhancing clinical trial systems with semantic technology to achieve the se-
mantic interoperability of large-scale and heterogeneous data would improve the
performance of clinical trials significantly. Those semantically-enabled systems
would achieve efficient and effective reasoning and data processing services in
various settings of clinical trials systems.
In this paper, we propose an approach of semantically enabled systems for
clinical trials. The proposed approach has been implemented in the system called
SemanticCT1. The system provides semantic integration of various data in clini-
cal trials. The system is designed to be a semantically enabled system of decision
1 http://wasp.cs.vu.nl/sct
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support for various scenarios in medical applications. SemanticCT has been se-
mantically integrated with various data, which include various trial documents
with semantically annotated eligibility criteria and large amount of patient data
with structured EHR and clinical medical records. Well-known medical termi-
nologies and ontologies, such as SNOMED, LOINC, etc., have been used for the
semantic interoperability.
SemanticCT is built on the top of LarKC (Large Knowledge Collider), a plat-
form for scalable semantic data processing2. With the built-in reasoning support
for large-scale RDF/OWL data of LarKC, SemanticCT is able to provide vari-
ous reasoning and data processing services for clinical trials, which include faster
identification of eligible patients for recruitment service and efficient identifica-
tion of eligible trials for patients.
The contribution of this paper is: (1) a framework that enables semantic
technologies for medical tasks related to the domain of clinical trials. (2) a proof
of concept of the framework by SemanticCT with a focus on three tasks: (i)
semantic search for clinical trials and patient data,(ii) trial finding for patients,
(iii) identifying patients for a trial.
This paper is organized as follows: Section 2 presents the general ideas of
semantically enabled systems for clinical trials. In section 3 we focus on three
tasks in the clinical trial domain: search in clinical trials and patient data, trial
finding for patients and identifying eligible patients for trials. Section 4 describes
a formalization of eligibility criteria of clinical trials. Section 5 proposes the
architecture of SemanticCT and describes various services and interfaces of the
system. Section 6 discusses the related work and make the conclusions.
2 Approach
The goal of SemanticCT is to exploit semantic techniques in the domain of
medical trials such that several tasks like trial finding and identifying eligible
patients for trials can be supported. In this section we describe the semantic data
integration and the platform. Notice that we use existing semantic technologies,
available medical ontologies, data sources, and semantic annotaters.
2.1 Semantic Data Integration
Semantic data integration of various data in clinical trials is a basic step to
build a semantically enabled system for clinical trials. Many existing trial data
are usually represented as XML data with the standard fields. For example,
the clinical trial service in the U.S. National Institutes of Health3 provides the
structured CDISC 20 fields of XML-encoded trial data. We can convert those
XML data into standard semantic data, like RDF NTriple data with the anno-
tations of medical ontologies or terminologies, like SNOMED, LOINC, MESH
and others. Those ontologies can be used individually, or in a group with the
2 http://www.larkc.eu
3 http://www.clinicaltrials.gov
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ontology alignments which are provided by the BioPortal ontology service4 or
other alignment tools. LinkedCT5 provides large-scale semantic data of clinical
trials with the standard formats of Linked Open Data in the Semantic Web.
The semantic annotations of clinical trials can be obtained by using many
semantic annotation tools/systems, which have been developed by the commu-
nity of the Semantic Web. BioPortal and MetaMap6 provide satisfying services
for semantic annotations with biomedical ontologies. Those annotation data are
also represented as XML ones. Similarly it is easy to use XSLT to convert those
XML encoded data into RDF NTriple ones. This means that for semantic inter-
operability we can exploit the available mappings among ontologies or to load
an own allignment as RDF NTriples.
Some EHR prototype systems have been developed to support some kinds
of semantics-enriched patient data. Those patient data can be accessed via the
servers provided by those systems. However, real patient data are usually pro-
tected and not allowed for public access, because of the legal issue and privacy
reason. We have developed a knowledge-based patient data generator which can
synthesize required patient data for the purpose of tests by using some domain
knowledge to control the data generation and make the generated data look like
realistic ones[6].
In the paper we take three tasks into account: search in clinical trials or
patient records, trial finding for patients, and identifying eligible patients for
trials. For our feasibility tests we use clinical trials of breast cancer and we
integrated the following data in SemanticCT:
Clinical Trials. We got the XML-encoded data of 4665 clinical trials of
breast cancer from the official NCT website www.clinicaltrials.gov, and used
XSLT to convert the XML-encoded data into RDF NTriple data, which consists
of 1,200,565 triples and 335, 507 entities.
Medical ontologies. We got the latest release of SNOMED terminologies
and converted them into RDF NTriple data. The concepts and definitions of con-
verted SNOMED consists of 4,048,457 triples, which correspond with 2,046,810
entities.
Semantic annotations of clinical trials. We used the semantic annotation
server of BioPortal to obtain the XML-encoded semantic annotations of the
4665 clinical trials with the medical terminologies/ontologies such as SNOMED,
LOINC, HL7, MESH, RxNorm, and EVS. We converted the semantic annotation
data into RDF NTriple. The total data size is about 3.0 GB. For the experiment,
we load the semantic annotation data with the SNOMED concepts only. This
part of data consists of 106,334 triples (454MB data).
Patient Data. We used APDG (Advanced Patient Data Generator), a
knowledge-based patient data generator, to create 10,000 patient data of breast
cancer, which cover the main properties of female breast cancer patients, like
demographic data (e.g., gender and age), diagnosis, TNM stage (T for primary
tumor, N for regional lymph nodes, and M for distant metastasis), hormone
4 http://bioportal.bioontology.org/
5 http://linkedct.org/
6 http://metamap.nlm.nih.gov/
4 Zhisheng Huang, Annette ten Teije, and Frank van Harmelen
receptor status, e.g., the status of ER (Estrogen Receptor), PR (Progesterone
Receptor), and HER2 (Human Epidermal Growth Factor Receptor 2), etc. We
have collected the domain knowledge from medical literature (like PubMed) and
web pages (like those from Wikipedia) and encoded those domain knowledge to
control the generation of patient data and make the generated patient data look
like realistic ones[6]. The generated patient data set consists of 660,000 triples.
Thus, the total loaded RDF NTriple data are over 6 million triples. It is suffi-
cient for a demonstration prototype which runs at an ordinary laptop (dual core
and 4GB memory) with extremely good performance. Most SPARQL queries in
SemanticCT can be finished within one second. Thus, the time performance is
not a big issue. What we concern mainly is whether such an approach can be
used for supporting clinical trial tasks by developing a trial finding service and
a patient recruitment service.
2.2 Semantic Platform
There have been several well-developed triple stores which can be used to serve as
a semantic platform to build SPARQL endpoints for the services of querying over
large-scale semantic data. Well-known triple stores are OWLIM7 and Virtuoso8.
Those triple stores usually support for basic RDFS reasoning over semantic data.
LarKC is a platform for scalable semantic data processing. OWLIM is used
to be the basic data layer of LarKC. LarKC fulfills the needs in sectors that
are dependent on massive heterogeneous information sources such as telecom-
munication services, biomedical research, and drug-discovery[4]. The platform
has a pluggable architecture in which it is possible to exploit techniques and
heuristics from diverse areas such as databases, machine learning, cognitive sci-
ence, the Semantic Web, and others. LarKC provides a number of pluggable
components: retrieval, abstraction, selection, reasoning and deciding. In LarKC,
massive, distributed and necessarily incomplete reasoning is performed over web-
scale knowledge sources[10]. One of our clinical trial task requires a new reasoning
component (see section 4) which can be plugged in the LarKC platform.
3 Tasks in clinical trial domain
There are a large number of tasks in the domain of clinical trials. In this paper
we focus on the tasks search, trial finding for patients and identifying eligi-
ble patients for trials with the main question in mind whether the approach
of semantically enabled system for clinical trials can support those knowledge
intensive tasks.
3.1 Search
SemanticCT provides various search services over large-scale integrated data:
clinical trials, medical ontologies and patient data (see section 2.1). The seman-
tic integration is realised by several available medical ontologies and mappings
7 http://www.ontotext.com/owlim
8 http://virtuoso.openlinksw.com/
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between those ontologies from BioPortal. We also provide the service for brows-
ing semantically annotated eligibility criteria of trials, search services for patient
data browsing and specific patient finding, such as, show all triple-negative breast
cancer patients. These search facilities are all realized by enabling semantic tech-
nologies into the domain of clinical trials.
3.2 Trial Finding for Patients
The trial finding service is one which searches for suitable trials for a given
patient. Namely, based on the patient data, the system will check the requirement
of clinical trials with the patient data to see whether or not the trial can be
considered as a candidate trial for further deliberation by the patient and the
clinician to make the decision. Some requirements (such as gender and age) have
been structured in the original XML data. Some of those requirements are stated
in the eligibility criteria (i.e., inclusion criteria or exclusion criteria), which are
represented in natural language text. There are different approaches to deal
with the information in text. We can either use SPARQL queries with regular
expressions over eligibility criteria, or SPARQL queries directly over semantic
annotations of eligibility criteria, or formalize the text by using some kind of
formalization to make the structured eligibility criteria.
Given a patient data, it seems to be ideal to check if all the properties of
a patient meets the requirements of a trial. However, we have found that it is
not necessary, because checking with a few properties are sufficient to reduce
significant amount of candidate trials and result in a small amount of trials for
further deliberation.
For the experiment, we select just a small set of checking items, which consists
of some structured fields, such as demographic data (gender and age), and some
unstructured data (i.e., those in the text of eligibility criteria) such as stage,
menopausal status, and hormone receptor status. The latter can be checked
by using regular expressions with filters in SPARQL queries. Of course, we are
interested in the trials which are currently recruiting, rather than those which
have been completed. Thus, the initial SPARQL query of trial finding for a
female patient aged 40 at stage 2 can be represented as follows:
PREFIX ...
select distinct ?ctid ?summary ?criteria
where {
?ct rdf:type sct:ClinicalTrial.
?ct sct:NCTID ?ctid.
?ct sct:EligibilityGender ’Female’.
?ct sct:OverallStatus "Recruiting".
?ct sct:EligibilityMinAge ?minage.
?ct sct:EligibilityMaxAge ?maxage.
?ct sct:BriefSummary ?summary.
?ct sct:EligibilityCriteriaTextblock ?criteria.
FILTER(?minage <= ’40 Years’&& ?maxage >= ’40 Years’).
FILTER regex(str(?criteria), ’stage 2’).}
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In the query above, the regex ’stage 2’ is used to match the stage in the
eligibility criteria. The way of text matching is not sufficient to find all the
targeted information. We can extend the regular expressions to cover various
expressions which talk about the stage in natural language text. It is quite
clear that we cannot exhaust all the expressions which talk about the stage in
natural language text. Furthermore, the query cannot make a distinction between
the text appears in inclusion criteria and that in exclusion criteria, unless we
introduce more complex regular expressions which can detect the beginning and
the ending of those criteria.
We add checking on more properties of patients, like menopausal status and
hormone receptor status. That would reduce more candidate trials. Such reduc-
tion is very useful for clinicians. Table 1 summarizes the results of trial finding
with those selected properties for 11 randomly selected tests. Actually each test
represents a type of patients with their corresponding properties. From the table,
we know that just a few property checking would reduce significant amount of
candidate trials and result in only a few trials for further decision. The maximal
number of candidate trials is 28 and the minimal number of candidate trials is 3.
We have also detected the problem that some item checking by regular expres-
sions cannot deal with negation information correctly, in particular, for those
appear in exclusion criteria. For example, for checking on ’hormone receptor
status’, four trials have been mistakenly identified.
Patient Age Stage Found Menopausal RT HR RT FF EF Precision
ID Trial Status Status Trial (%)
1000001 40 0 19 premeno 1 ER+,PR-,HER2+ 2 16 1 93.75
1000302 67 2 16 postmeno 0 ER-,PR-,HER2+ 2 14 0 100
1001422 61 1 11 perimeno 0 ER+, PR+, HER2- 0 11 0 100
1001548 64 1 11 postmeno 0 ER+, PR-, HER2- 0 11 0 100
1002017 52 2 18 perimeno 2 ER+,PR-,HER2+ 1 15 0 100
1003862 69 0 32 postmeno 0 ER-,PR+,HER2+ 4 28 0 100
1004121 42 1 17 perimeno 3 ER-,PR+, HER2- 4 10 0 100
1005035 41 0 19 premeno 1 ER-,PR+,HER2+ 2 16 1 93.75
1006125 47 0 19 perimeno 1 ER-,PR-,HER2+ 2 16 1 93.75
1007321 75 3 26 postmeno 0 ER-,PR-,HER2- 23 3 0 100
1009934 64 3 27 postmeno 0 ER+,PR-,HER2- 4 23 1 95.65
Average 56.55 19.55 0.73 4.4 14.82 0.36 97.90
Table 1. Trial Finding for Patient by SPARQL Queries with Regular Expressions. RT:
Reduced Trials, HR: Hormone Receptor, FF Trials: Finally Found Trials, EF: Error
Found
This feasibility test shows us that SPARQL queries with regular expressions
are useful and promising to select trials for a specific patient.
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3.3 Identifying Eligible Patients for Trials
Another task is to provide faster identification service of eligible patients for clin-
ical trials. That requires the formalization of eligibility criteria, so that match-
ing patient data with formalized eligibility criteria for automatic identification
of clinical trials for patients. In [5] we propose a rule-based formalization for
eligibility criteria, which is briefly discussed in the next section 4.
We have picked up 10 clinical trials randomly and formalized their eligibility
criteria by using the rule-based formalization. We have tested the system for
automatically identifying eligible patients for those selected trials. The system is
able to find minimally 241 patients and maximally 750 patients out of the 10,000
patients for each trial, within less five seconds, for the system which is running
on an ordinary laptop (dual core and 4GB memory)[5]. This formalization is also
useful for trial finding service, because it can provide exactly matching on the
data, without relying on exhaustive regular expression patterns. This feasibility
test shows us that rule-based formalization of eligibility criteria for identifying
eligible patients for trials is doable in an effective and efficient way. Clearly the
next step is to set-up an experiment with real patient data and validation of the
results with a clinician.
4 Rule-based Reasoning
For reasoning over various semantic data for clinical trials, SPARQL queries
are not always powerful and flexible enough to specify complex requirements of
eligibility criteria. In the experiments with automatic identification of eligible
patients, we have observed that SPARQL queries with regular expressions are
not always sufficient, for instance, for checking eligibility criteria.
For example, in order to check if an eligibility criteria require a patient of
the stage 2 breast cancer, we have to use a regular expression to cover various
expressions which talk about the stage in natural language text, like this:
FILTER regex(str(?criteria),
’stage 2|stage II |stage 0, 1, 2|stage I, II|stage IIa|stage IIb’)
As we have discussed before, it is quite clear that we cannot exhaust all the
expressions which talk about the stage in natural language text. Therefore, that
would result in some eligibility criteria uncheckable at the run time (i.e., query-
ing time). We have developed a rule-based formalization of eligibility criteria
for clinical trials[5], so that eligibility criteria in natural language text can be
processed oﬄine, i.e., when their formalizations are generated.
Compared with existing formalizations, the rule-based formalization is more
efficient and effective, because of the declarative form, easy maintenance, reusabil-
ity and expressivity[5].
There exist various rule languages which can be used for the formalization of
eligibility criteria. In the researches of artificial intelligence, logic programming
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languages, like Prolog, are well known and popular rule-based languages. Sev-
eral rule-based languages, like SWRL 9 and RIF10, have been proposed for the
semantics-enable rule-based language. In biomedical domain, the Arden syntax
11 has been developed to formalize rule-like medical knowledge. However, com-
pared with logic programming language Prolog, both SWRL, RIF and the Arden
syntax have very limited functionalities for data processing.
In SemanticCT, the rule-based formalization is developed based on the logic
programming language Prolog. We select the SWI-Prolog12 as the basic language
for the rule-based formalization of eligibility criteria, because of its Semantic Web
support and powerful processing facilities [8,9].
We formalize the knowledge rules of the specification of eligibility criteria of
clinical trials with respect to the following different levels of knowledge: trial-
specific knowledge, domain-specific knowledge, and common knowledge.
Trial-specific Knowledge Trial-specific knowledge are those rules which
specify the concrete details of the eligibility criteria of a specific clinical trial.
Those criteria are different from a trial to another trial.
Given a patient ID, we suppose that we can obtain its patient data through
the common knowledge of the interface with SPARQL endpoints and its internal
data storage. Thus, in order to check if a patient meets an inclusion criterion,
we can check if its patient data meet the criterion.
Furthermore, we would not expect to check all the criteria with respect to the
patient data, because some of those required data may be missing in the patient
data. We introduce a special predicate getNotYetCheckedItems to collect those
criteria which have not yet been formalized for the trial.
For example, the inclusion criteria in the trial NCT00002720 can be formal-
ized as follows:
meetInclusionCriteria(_PatientID, PatientData, CT,
NotYetCheckedItems):-
CT = ’nct00002720’,
breast_cancer_stage(PatientData, ’1’),
invasive_breast_cancer(PatientData),
er_positive(PatientData),
known_pr_status(PatientData),
age_between(PatientData, 65, 80),
postmenopausal(PatientData),
getNotYetCheckedItems(CT, NotYetCheckedItems).
Which states that the inclusion criteria include: i) Histologically proven stage
I, invasive breast cancer, ii) Hormone receptor status: Estrogen receptor posi-
tive and Progesterone receptor positive or negative, iii) Age: 65 to 80, and iv)
Menopausal status: Postmenopausal.
Domain-specific Knowledge Those trial-specific rules above may involve
some knowledge which are domain relevant, i.e., the domain knowledge, which
9 http://www.w3.org/Submission/SWRL/
10 http://www.w3.org/TR/rif-overview/
11 http://www.hl7.org/special/Committees/arden/index.cfm
12 http://www.swi-prolog.org/
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are trial independent. We formalize those part of knowledge which are relevant
with domain knowledge in the libraries of domain-specific knowledge. For ex-
ample, for clinical trials of breast cancer, we formalize the knowledge of breast
cancer in the knowledge bases of breast cancer, a domain-specific library of rules.
An example of this type of knowledge is a patient of breast cancer is triple
negative if the patient has estrogon receptor negative, progesterone receptor
negative and protein HER2 negative status. It can be formalized in Prolog as
follows:
triple_negative(Patient):- er_negative(Patient),
pr_negative(Patient),
her2_negative(Patient).
We consider patient data as a set of property-value pairs. A general format of
patient data, called the PrologCMR format, is designed to be a list of property-
value pairs. This general format of patient data is flexible to represent the data
from different formats of CMRs, because we can design a CMR-specific interface
to obtain the corresponding data via different data servers, which can be a
SPARQL endpoint, internal data storage server, or a database server[5]. Then,
we can convert the patient data into one in the PrologCMR format. We introduce
the general predicate getItem(PatientData, Property, Value) to get the value of
the property from the patient data.
For example, these receptor status can be straightforward formalized as fol-
lows:
er_positive(PatientData):- getItem(PatientData, er, ER),
ER = ’positive’.
Common Knowledge The specification of the eligibility criteria may in-
volve some knowledge which are domain independent, like the knowledge for
temporal reasoning and the knowledge for manipulating semantic data and in-
teracting with data servers, e.g. how to obtain the data from SPARQL endpoints.
We formalize the knowledge in several rule libraries, which can be reusable for
different applications.
Example of this type of knowledge is temporal reasoning with constructs like
last-month.
lastmonth(LastMonth):- today(Today),
Today = date(_Year, ThisMonth, _Date),
ThisMonth > 1,
LastMonth is ThisMonth - 1.
lastmonth(LastMonth):- today(Today),
Today = date(_Year, ThisMonth, _Date),
ThisMonth is 1,
LastMonth is 12.
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Based on the SWI-Prolog’s Web libraries, we can develop the interface with
SPARQL endpoints to obtain semantic data (e.g. semantics-enable patient data
and medical ontologies) for the rule-based formulation of eligibility criteria.
Fig. 1. The architecture of SemanticCT.
This reasoning component is developed as a LarKC component for the task
of identifying eligible patients for trials. The rule-based reasoning component
is also useful for trial finding service, because it can provide exactly matching
on the data, without relying on exhaustive regular expression patterns. In the
future we want to use this component for trial finding for patients. This requires
that all eligibility criteria of the trials are modeled in this rule-based approach.
5 System
5.1 Architecture
The architecture of SemanticCT is shown in Figure 1. SemanticCT Management
plays a central role of the system. It launches a web server which serves as the
application interface of SemanticCT, so that the users can use a web browser
to access the system locally (i.e., from the localhost) or remotely (i.e., via the
Web). SemanticCT Management manages SPARQL endpoints which are built
as SemanticCT workflows. A generic reasoning plug-in in LarKC provides the
basic reasoning service over large-scale semantic data, like RDF/RDFS/OWL
data. SemanticCT Management interacts with the SemanticCT Prolog compo-
nent which provides the rule-based reasoning[5,3].
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Fig. 2. The GUI of SemanticCT.
LarKC, which consists of the LarKC core for plug-in and workflow man-
agement and the LarKC data layer, serves as the infrastructure of SemanticCT
for semantic data management. The LarKC data layer manages the semantic
data repositories of SemanticCT. Those semantic data repositories consist of i)
biomedical terminologies or ontologies, such as SNOMED CT, LOINC, MeSH,
RxNorm, etc., ii) semantic data of clinical trials, like those from LinkedCT, or
semantic data which are converted from the original XML-encoded data of clin-
ical trials, iii) semantic annotation data of trials, which are generated from the
biomedical semantic annotation servers, and iv) patient data, which can be the
semantic data obtained from EHR systems, or created by the knowledge-based
patient data generator[6]. Those semantic data repositories can be located locally
or distributively.
Fig. 3. The interface of semantic search.
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Fig. 4. Semantic Annotation
5.2 Interface and Service
For the demonstration prototype of SemanticCT, we merge the interfaces for
various groups of users into a unique one on a Web browser, without consider-
ing their data protection issues, like access authority and password checking. A
screenshot of the interface of the demonstration prototype SemanticCT is shown
in Figure 2. Notice the several tabs that are available for various services and
different types of users and discussed below.
– Semantic search: Figure 3 shows the interface of the semantic search, with
a SPARQL example which searches for all recruiting phase 3 trials for fe-
male patients with the age between 70 and 75. We provide a set of SPARQL
query templates, so that the users can select some of them and change some
parameters of the templates to make their own queries (see SPARQL exam-
ples)
– Keyword search: We provide the ordinary search by using keywords to search
over the eligibility criteria, or summaries of clinical trials. The extended key-
word search provides complex keyword searches with the Boolean operators.
– Eligibility criteria: the eligibility criteria of the trial are shown.
– Annotated criteria: the service for browsing semantically annotated eligibil-
ity criteria of trials, see Figure 4.
– For patients: One of the main services in SemanticCT is the trial finding
service. Currently, we provide the trial finding service by using SPARQL
queries with regular expressions. The interface of patient services is shown
in Figure 5. Notice that the SPARQL query is not visible for the user, but
behind the button ”show the CTs for this patient”.
– For clinicians: SemanticCT provides several services for clinicians (see Figure
6). Those services include i) patient data browsing, ii) specific patient find-
ing, such as, show all triple-negative breast cancer patients, and iii) patient
recruitment for the selected clinical trial. The interface of clinician service
for patient recruitment is shown in Figure 6. Notice that patient recruitment
service is based on the rule-based formalization of the eligibility criteria.
– For Researchers: Semantic search for patient recruitment is one of the main
services here.
Notice as well that the user can select an ontology from a list. In Figure 2
SNOMED is selected.
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Fig. 5. Patient Service view and Trial Finding
Fig. 6. Clinician services view and Rule-based formalization for Eligible Patient Iden-
tification
6 Discussion and Conclusion
6.1 Related Work
One of the obstacle to automate a clinical task like improving cohort selection
for clinical trials is the need to bridge the semantic gap between raw patient
data, such as laboratory tests or specific medications, and the way a clinician
interprets this data. In [7] they presented a feasibility study for an ontology-
based approach to match patient records to clinical trials. This is inline with
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SemanticCT which enables to bridge this semantic gap as well by exploiting
ontologies.
The work in [1] is also focused on the enabling of the semantic interoper-
ability between clinical research and clinical practice. Their approach is based
on a SOA-oriented approach combined with the exploitation of ontologies which
forms an ”intelligence” layer for interpreting and analyzing existing data, which
is dispersed, heterogeneous information, which is to a great extend publicly avail-
able. In [2] the authors present a method, entirely based on standard semantic
web technologies and tool, that allows the automatic recruitment of a patient to
the available clinical trials. They use a domain specific ontology to represent data
from patients’ health records and use SWRL to verify the eligibility of patients
to clinical trials. Although we propose an even more expressive language (e.g.,
support for temporal reasoning and others) for modeling the eligibility criteria,
this is in the same spirit as our approach. Furthermore, we use a general frame-
work for specifying the eligibility criteria in three types of knowledge which can
be reused.
6.2 Discussion
In this paper, we have presented a semantically-enabled system for clinical trials.
We have proposed the architecture of SemanticCT, which have been designed
to build on the top of LarKC, a platform for scalable semantic data processing.
The logic programming language Prolog has been introduced to a rule-based
formulization of eligibility criteria for clinical trials. SemanticCT has been se-
mantically integrated with large-scale and heterogeneous data.
We have conducted several experiments for reasoning and data processing
services over SemanticCT. The experiment of trial finding service shows that
SPARQL queries with regular expressions are useful to deal with the information
which can be easily obtained by the processing (like menopausal status and
hormone receptor status). The experiment of the rule-based formalization shows
that it is efficient and effective approach for faster identifying eligible patients.
What we have implemented and tested is just a prototype of SemanticCT. Thus,
it provides only a basic step for developing semantically enabled systems for
clinical trials.
6.3 Future work
There are many interesting issues for future work of SemanticCT, which include
trial finding by using rule-based reasoning, more comprehensive workflow pro-
cessing for decision support procedure, deeper reasoning with biomedical ontolo-
gies, personalized information services for patients, clinicians, and researchers,
etc. We are going to provide more extended services for clinicians, which include
finding relevant and latest literature like those from PubMed for the selected
patient, and showing prognosis for selected patients. The existing implemented
prognosis service in SemanticCT is quite simple, for it shows only the 5 year
survival rate, based on the TNM stage of patients. A comprehensive prognosis
service would be able to make analysis of all the relevant patient data to finding
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most-relevant clinical evidence for the prognosis analysis. We will continue the
development of SemanticCT and deploy it in real application scenarios.
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